InnovHeart
  • Welcome
  • Clinical Needs
  • Who We Are
  • News
  • Careers
  • Contact
Seleziona una pagina
InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up

InnovHeart Reports Successful First-in- Human Implantation of its Saturn Transcatheter Mitral Valve with Excellent 30-day Follow-up

da Chiara | Set 24, 2020 | Press release

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation (MR), announced today the successful Firstin-Human implantation of its proprietary Saturn Transcatheter Mitral Valve along with...
Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million

Transcatheter Mitral Valve Replacement Company InnovHeart Closes Series B Financing of €20 Million

da Chiara | Ago 7, 2020 | Press release

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing.  Founded in 2015 by Giovanni Righini, a 30-year veteran of...
Presentation of Saturn Device at TCT – September 2019

Presentation of Saturn Device at TCT – September 2019

da Chiara | Set 11, 2019 | News

Saturn Device was presented at 2019 TCT held on September 25–29 in San Francisco – California. See the presentation here.
InnovHeart Elects Keith D. Dawkins MD as Chairman of the Board

InnovHeart Elects Keith D. Dawkins MD as Chairman of the Board

da Chiara | Set 6, 2018 | Press release

Dr. Dawkins is transitioning from his position as a member of the InnovHeart Board which he joined in May of this year. Dr. Dawkins has more than 35 years experience as both a practicing phys ician and an executive within the medical device industry. He currently also...
InnovHeart Appoints Keith D. Dawkins, M.D., as Board Member

InnovHeart Appoints Keith D. Dawkins, M.D., as Board Member

da Chiara | Mag 7, 2018 | Press release

InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease, announces the appointment of veteran medical device executive Keith D. Dawkins, M.D., to a newly created position on its Board of...
« Post precedenti

©COPYRIGHT - INNOVHEART SRL 2024 - Capitale sociale € 236.096,00 Cod.fisc.PIVA e Registro Imprese di Milano-Monza-Brianza-Lodi 09291430966 - REA di Milano 2081285

Cookies Policy - Privacy Policy